vaccination-1215279_960_720

UK secures another two million COVID-19 vaccine doses from Moderna

November 30, 2020
Sales and Marketing COVID-19, Moderna, UK

The UK Government has expanded upon its previous negotiations with Moderna to secure an additional two million doses of its …

astrazeneca_sign_sky

Japan approves AstraZeneca’s Forxiga for chronic heart failure

November 30, 2020
Sales and Marketing AstraZeneca, Forxiga

Japan’s Ministry of Health, Labour and Welfare (MHLW) has announced the authorisation of AstraZeneca’s Forxiga as a treatment for chronic …

cliche_hacker_and_binary_code_26614834084

AstraZeneca targeted by suspected North Korean hackers

November 27, 2020
Medical Communications

Hackers suspected to be operating from North Korea have tried to break into the systems of AstraZeneca, two people with …

Japan approves Astellas and FibroGen’s Evrenzo for chronic kidney disease patients currently not receiving dialysis

November 27, 2020
Medical Communications, Sales and Marketing Astellas, Japan, fibrogen

Japan’s Ministry of Health, Labour and Welfare (MHLW) has passed approval for Astellas and FibroGen’s Evrenzo (roxadustat) in the treatment …

1200px-razrabotka_vakciny

New trial expected for AstraZeneca’s COVID-19 vaccine

November 27, 2020
Medical Communications

AstraZeneca is expected to launch new global trials to assess the efficacy of its COVID-19 vaccine using a lower dosage.  …

1200px-european_flag_in_karlskrona_2011

EU fines Teva and Cephalon for keeping cheap sleep disorder medicine off the market

November 27, 2020
Medical Communications

The European Union has fined Teva and Cephalon for colluding to keep a cheap alternative sleep disorder medicine off the …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

November 27, 2020
Medical Communications

The top ten news stories this week once again focus on COVID-19 treatments, with the Canadian Government securing 26,000 doses …

neuroblastoma_103

Y-mAbs announces FDA approval of Danyelza for the treatment of Neuroblastoma

November 26, 2020
Business Services

Y-mAbs Therapeutics has announced that the FDA has approved Danyelza in combination with granulocyte-macrophage colony-stimulating factor (“GM-CSF”), for the treatment …

1200px-covid-19_warning_matrix_sign_beastfair_pontefract_21st_june_2020_003

England COVID-19 spread levelling off after cases fell slightly

November 26, 2020
Business Services

Coronavirus infection rates across England are levelling off after a slight decrease in cases last week, according to the Office …

money_and_pills_in_three_colors

Plan to import Canadian drugs to the US challenged by pharmaceutical lobby in Florida

November 26, 2020
Business Services

The proposed plan to import cheaper Canadian drugs to Florida is being challenged by the US pharmaceutical lobby in court.  …

progeria

FDA approves first drug to treat rare rapid ageing condition progeria

November 26, 2020
Business Services

The FDA has approved the first drug to treat the rare genetic disorder progeria, a rare condition which causes cells …

astrazeneca_sign_sky

Philippines poised to secure two million AstraZeneca COVID-19 vaccine doses

November 26, 2020
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

The Philippines is set to imminently seal a deal with AstraZeneca for two million doses of AstraZeneca’s COVID-19 vaccine, it …

lilly_building_with_american_flag_web

Canada secures 26,000 doses of Lilly therapy to treat COVID-19 in $32.5m deal

November 25, 2020
Manufacturing and Production, Research and Development COVID-19, Canada

The Canadian Government has partnered up with Eli Lilly to secure 26,000 doses of the company’s monoclonal antibody therapy bamlanivimab …

flu_vaccination_grippe_5115654021_5

Largest clinical trial treating mild to moderate COVID-19 patients to take place in Africa

November 25, 2020
Research and Development

The world’s largest clinical trial investigating the treatment of patients with mild to moderate COVID-19 is set to begin in …

1200px-eurotunnel_11

ABPI warns that no-deal Brexit could disrupt medicines and vaccine delivery

November 25, 2020
Research and Development

The Association of the British Pharmaceutical Industry (ABPI) has warned that the supplies of crucial medicines and vaccines could be …

1200px-oxycontin_branded_oxycodone_10mg_oc_side

Purdue Pharma pleads guilty to its role in the opioid crisis

November 25, 2020
Research and Development

Purdue Pharma has pleaded guilty to criminal charges over its role in fueling the opioid crisis which was driven by …

covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 25, 2020
Research and Development

The coronavirus news this week sees more companies release their coronavirus vaccine results, with Pfizer and BioNTech backing up their …

pharmafocus_december_2020_cover

The December 2020 issue of Pharmafocus is available to read free online now!

November 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing

The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …

fdaoutsideweb

FDA expands approval of Genentech’s Xofluza for post-exposure prevention of influenza

November 24, 2020
Manufacturing and Production, Sales and Marketing FDA, Xofluza, influenza

Genentech has secured FDA approval for Xofluza (baloxavir marboxil) for the post-exposure prevention of influenza in patients at least 12 …

british_houses_of_parliament

UK deaths currently a fifth higher than normal levels

November 24, 2020
Manufacturing and Production

Deaths across the UK are a fifth higher than normal, according to new government data.  Numbers released from UK Government …

The Gateway to Local Adoption Series

Latest content